|1.||Xie, Yan-Ming: 9 articles (09/2014 - 09/2012)|
|2.||Wang, Lian-Xin: 7 articles (09/2014 - 09/2012)|
|3.||Tang, Hao: 5 articles (09/2014 - 09/2012)|
|4.||Xie, Yanming: 4 articles (01/2015 - 10/2011)|
|5.||Yang, Wei: 4 articles (09/2014 - 10/2011)|
|6.||Zhuang, Yan: 4 articles (09/2014 - 10/2011)|
|7.||Zhang, Wen: 4 articles (12/2013 - 08/2009)|
|8.||Yu, Bo-Yang: 3 articles (10/2015 - 04/2011)|
|9.||Wang, Yi: 3 articles (01/2014 - 02/2009)|
|10.||Lin, Li-Na: 3 articles (02/2011 - 02/2008)|
02/01/2010 - "Shenmai injection (SMI), a mixture of Radix Ginseng and Radix Ophiopogonis, is one of the most popular herbal medicinal products and is widely used for the treatment of coronary atherosclerotic cardiopathy and viral myocarditis. "
08/14/2009 - "Shenmai injection (SMI), one of the most popular herbal preparations, is widely used for the treatment of coronary atherosclerotic cardiopathy and viral myocarditis. "
04/01/2013 - "Shenmai injection (SMI) is a popular herbal preparation that is widely used for the treatment of atherosclerotic coronary heart disease and viral myocarditis. "
09/01/2013 - "Shenmai injection is widely used in clinical pediatrics, and is reported to show effectivenss for conditions such as viral myocarditis, pneumonia, neonatal hypoxic ischemic encephalopathy, neonatal scleroderma, diarrhea and other diseases. "
|2.||Coronary Disease (Coronary Heart Disease)
09/01/2013 - "In order to understand the treatment of coronary heart disease with parenterally administered Shenmai and the efficacy of combination therapies, the study selected 18 hospitals for analysis. "
09/01/2013 - "[Real-world study in analysis of effects on concomitant medications with parenterally administered shenmai for coronary heart disease]."
12/01/2012 - "CNKI (1979 to December 2011), VIP (1989 to December 2011), and Wanfang Data (1987 to December 2011) were retrieved for literatures concerning randomized controlled trials of Shenmai injection in the treatment of coronary heart disease. "
09/01/2013 - "When Shenmai is used with combination therapies for coronary heart disease, treatment guidelines should be complied with. "
09/01/2013 - "Data of in-patients receiving parenterally administered Shenmai for a diagnosis of coronary heart disease was analyzed using; the Apriori algorithm to model use, Clementine 12.0 linkage analysis to find correlations between various drugs, and chi-square test for commonly used combination therapies to ascertain the cure rate. "
09/01/2012 - "To analyze the literature about clinical efficacy of Shenmai injection for tumor treatment, and understand preliminarily the medicine law and effect of Shenmai injection. "
09/01/2014 - "The study was to research the clinical characteristics of Shenmai injection treating tumor based on hospital information system, including the characteristics of the age, the sex, the dosage, the course of the treatment and the combination drugs. "
09/01/2014 - "The information from HIS showed that tumor patients used Shenmai injection were most quinquagenarian with smooth condition. "
09/01/2014 - "The data of tumor patients injected with Shenmai injection was analyzed. "
09/01/2014 - "[Clinical characteristics research of shenmai injection treating tumor based on hospital information system in real world]."
|4.||Respiratory Insufficiency (Respiratory Failure)
07/01/2006 - "[Effects of shenmai injection on the clinical efficacy of noninvasive ventilation in patients with severe respiratory failure caused by chronic obstructive pulmonary disease]."
06/01/2002 - "To study the effect of Shenmai injection (SMI) on diaphragmatic fatigue in children with respiratory failure. "
06/01/2002 - "[Effect of shenmai injection on diaphragmatic fatigue in children with respiratory failure]."
07/01/2006 - "To study the effect of Shenmai Injection (SMI) on the clinical efficacy of noninvasive positive-pressure ventilation (NPPV) in treating patients with severe respiratory failure (RF) caused by chronic obstructive pulmonary disease (COPD). "
12/01/2010 - "To examine the effects of modified Shenmai Yin on invigorating vital energy, promoting blood flow, and protection against neural impairment in an endotoxin-induced shock rat model. "
09/01/2013 - "Literature review and analysis of HIS data outcomes, are the two methods used to study the type of shock treated, dose and combinations of other medications used with parenterally administered Shenmai. "
09/01/2013 - "Therefore, parenterally administered Shenmai is a suitable treatment for shock. "
09/01/2013 - "[Literature review and hospital information system data real world clinical outcome analysis of role of parenterally administered shenmai in treatment of shock]."
09/01/2012 - "The currently available evidence showed that Shenmai injection plus conventional treatment group may decrease the fatality rate during hospitalization, the incidence of cardiac failure, shock and re-infarction. "
|1.||Plant Preparations (Preparation, Plant)
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|4.||Interleukin-6 (Interleukin 6)
|9.||Urokinase-Type Plasminogen Activator (Urokinase)
|1.||Drug Therapy (Chemotherapy)
|2.||Chinese Traditional Medicine (Traditional Chinese Medicine)
|4.||Positive-Pressure Respiration (PEEP)